DVA Strangle Strategy

DVA (DaVita Inc.), in the Healthcare sector, (Medical - Care Facilities industry), listed on NYSE.

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions.

DVA (DaVita Inc.) trades in the Healthcare sector, specifically Medical - Care Facilities, with a market capitalization of approximately $13.93B, a trailing P/E of 18.72, a beta of 0.91 versus the broader market, a 52-week range of 101-217.04, average daily share volume of 847K, a public-listing history dating back to 1995, approximately 76K full-time employees. These structural characteristics shape how DVA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.91 places DVA roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a strangle on DVA?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current DVA snapshot

As of June 30, 2026, spot at $222.51, ATM IV 31.80%, IV rank 14.13%, expected move 9.12%. The strangle on DVA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this strangle structure on DVA specifically: DVA IV at 31.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a DVA strangle, with a market-implied 1-standard-deviation move of approximately 9.12% (roughly $20.29 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DVA expiries trade a higher absolute premium for lower per-day decay. Position sizing on DVA should anchor to the underlying notional of $222.51 per share and to the trader's directional view on DVA stock.

DVA strangle setup

The DVA strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DVA near $222.51, the first option leg uses a $230.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DVA chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DVA shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$230.00$3.40
Buy 1Put$210.00$1.75

DVA strangle risk and reward

Net Premium / Debit
-$515.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$515.00
Breakeven(s)
$204.85, $235.15
Risk / Reward Ratio
Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

DVA strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on DVA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

DVA strangle profit and loss curve at expiration with breakevens and current spot markedDVA strangle payoff at expiration$0$5000$10000$15000$20000$100$200$300$400Underlying Price ($)P&L at Expiration ($)BE $204.85BE $235.15Spot $222.51
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-100.0%+$20,484.00
$49.21-77.9%+$15,564.29
$98.40-55.8%+$10,644.58
$147.60-33.7%+$5,724.87
$196.80-11.6%+$805.17
$246.00+10.6%+$1,084.54
$295.19+32.7%+$6,004.25
$344.39+54.8%+$10,923.96
$393.59+76.9%+$15,843.67
$442.78+99.0%+$20,763.38

When traders use strangle on DVA

Strangles on DVA are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the DVA chain.

DVA thesis for this strangle

The market-implied 1-standard-deviation range for DVA extends from approximately $202.22 on the downside to $242.80 on the upside. A DVA long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current DVA IV rank near 14.13% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on DVA at 31.80%. As a Healthcare name, DVA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DVA-specific events.

DVA strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DVA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DVA alongside the broader basket even when DVA-specific fundamentals are unchanged. Always rebuild the position from current DVA chain quotes before placing a trade.

Frequently asked questions

What is a strangle on DVA?
A strangle on DVA is the strangle strategy applied to DVA (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With DVA stock trading near $222.51, the strikes shown on this page are snapped to the nearest listed DVA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are DVA strangle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the DVA strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 31.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$515.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a DVA strangle?
The breakeven for the DVA strangle priced on this page is roughly $204.85 and $235.15 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DVA market-implied 1-standard-deviation expected move is approximately 9.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on DVA?
Strangles on DVA are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the DVA chain.
How does current DVA implied volatility affect this strangle?
DVA ATM IV is at 31.80% with IV rank near 14.13%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related DVA analysis